HEPH
Basic information
Region (hg38): X:66162671-66268867
Links
Phenotypes
GenCC
Source:
- hereditary hemochromatosis (Moderate), mode of inheritance: XL
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HEPH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 47 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 51 | 6 | 1 |
Variants in HEPH
This is a list of pathogenic ClinVar variants found in the HEPH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-66162755-A-T | not specified | Uncertain significance (Sep 14, 2022) | ||
X-66162843-T-C | not specified | Benign (Jul 31, 2024) | ||
X-66170558-A-C | not specified | Uncertain significance (Feb 01, 2023) | ||
X-66170607-A-G | not specified | Uncertain significance (Oct 20, 2023) | ||
X-66170668-G-A | not specified | Likely benign (Feb 06, 2024) | ||
X-66170673-G-A | not specified | Uncertain significance (Nov 20, 2023) | ||
X-66170711-C-G | not specified | Uncertain significance (Jan 03, 2024) | ||
X-66170736-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
X-66172339-T-C | not specified | Benign (Jul 31, 2024) | ||
X-66172363-C-A | not specified | Uncertain significance (Nov 24, 2024) | ||
X-66172389-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
X-66172449-G-T | not specified | Uncertain significance (Jan 24, 2024) | ||
X-66173643-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
X-66173699-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
X-66173775-T-C | not specified | Uncertain significance (Sep 27, 2021) | ||
X-66188382-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
X-66188389-G-A | not specified | Uncertain significance (Aug 15, 2024) | ||
X-66188404-A-G | not specified | Uncertain significance (Sep 26, 2024) | ||
X-66188411-C-A | not specified | Uncertain significance (Jun 17, 2024) | ||
X-66188425-G-C | not specified | Uncertain significance (Jun 24, 2022) | ||
X-66188430-G-T | not specified | Uncertain significance (Aug 12, 2021) | ||
X-66188491-C-A | not specified | Uncertain significance (Nov 13, 2023) | ||
X-66188500-A-G | not specified | Uncertain significance (Jan 07, 2022) | ||
X-66188534-G-T | not specified | Uncertain significance (Sep 22, 2021) | ||
X-66188538-C-T | not specified | Uncertain significance (Oct 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HEPH | protein_coding | protein_coding | ENST00000519389 | 21 | 106319 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000461 | 1.00 | 125713 | 10 | 21 | 125744 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.715 | 485 | 443 | 1.10 | 0.0000327 | 8011 |
Missense in Polyphen | 149 | 171.04 | 0.87115 | 3154 | ||
Synonymous | -1.96 | 188 | 157 | 1.20 | 0.0000109 | 2314 |
Loss of Function | 3.76 | 15 | 41.0 | 0.366 | 0.00000327 | 654 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000307 | 0.000260 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000297 | 0.000217 |
Finnish | 0.000377 | 0.000277 |
European (Non-Finnish) | 0.000164 | 0.000114 |
Middle Eastern | 0.000297 | 0.000217 |
South Asian | 0.000105 | 0.0000653 |
Other | 0.000226 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a ferroxidase for ferrous (II) to ferric ion (III) conversion and may be involved in copper transport and homeostasis. Implicated in iron homeostasis and may mediate iron efflux associated to ferroportin 1.;
- Pathway
- Porphyrin and chlorophyll metabolism - Homo sapiens (human);Mineral absorption - Homo sapiens (human);Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Metal ion SLC transporters;Iron uptake and transport
(Consensus)
Recessive Scores
- pRec
- 0.375
Intolerance Scores
- loftool
- 0.0196
- rvis_EVS
- 0.38
- rvis_percentile_EVS
- 75.65
Haploinsufficiency Scores
- pHI
- 0.221
- hipred
- N
- hipred_score
- 0.466
- ghis
- 0.481
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.388
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Heph
- Phenotype
- liver/biliary system phenotype; embryo phenotype; pigmentation phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; homeostasis/metabolism phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- copper ion transport;iron ion transport;cellular iron ion homeostasis;iron ion homeostasis;oxidation-reduction process
- Cellular component
- plasma membrane;integral component of membrane;basolateral plasma membrane;perinuclear region of cytoplasm
- Molecular function
- ferroxidase activity;copper ion binding;ferrous iron binding;oxidoreductase activity